David Oulès

Provide strategic and operational leadership supporting international commercial strategy and launch readiness for advanced gene therapies across multiple markets.

Key contributions:

• Support international commercial strategy execution and revenue performance across launch markets
• Drive cross-functional alignment (marketing, market access, medical, supply) to ensure successful therapy adoption and patient access
• Lead operational governance with country leadership to ensure commercial readiness and scalable treatment network activation
• Identify and mitigate operational and commercial risks impacting patient flow and market performance
• Contribute to patient journey optimization and treatment network strategy to accelerate therapy uptake

Led the European operational readiness and treatment network activation for the launch of a first-in-class CRISPR-Cas9 gene therapy.

Key achievements:

• Led activation of the first European treatment center, enabling treatment of the first patient in Europe
• Developed and deployed the treatment center activation model supporting commercial launch
• Coordinated cross-functional teams across commercial, medical, supply chain, and regulatory
• Contributed to improving customer experience and treatment pathways across international markets

Led the strategic development and activation of CAR-T treatment centers to support commercial expansion of advanced cell therapies.

Key contributions:

• Identified, activated and onboarded authorized treatment centers across France
• Partnered with hospital leadership to optimize operational workflows and patient pathways
• Supported commercial teams in treatment network expansion and therapy adoption
• Coordinated with European teams to ensure alignment between commercial objectives and operational capabilities

Led regional commercial performance and P&L delivery for a specialty cardiology portfolio, including the launch of a first-in-class heart failure therapy.

Key achievements:

• Managed a team of 10 sales representatives covering Western France
• Responsible for regional business performance representing €90M portfolio (47% of national sales)
• Successfully launched a first-in-class therapy in chronic heart failure
• Implemented multichannel customer engagement strategy (digital + field)
• Led regional care pathway transformation projects to accelerate patient access
• Delivered continuous growth and achievement of regional sales targets

Led regional sales strategy and team performance across respiratory portfolio including asthma and COPD.

Key contributions:

• Managed sales team and regional commercial performance
• Led launch preparation and execution for respiratory portfolio
• Implemented multichannel engagement strategy and digital tools
• Led regional change management during sales organization transformation

Hybrid commercial, operational and digital marketing leadership role supporting national strategy and regional sales performance.

Key contributions:

• Managed regional sales performance and delivery of commercial targets
• Led cross-functional regional coordination between commercial, medical, market access and institutional stakeholders
• Drove implementation of multichannel and digital customer engagement strategies in HIV specialty care
• Served as national CRM leader, supporting digital transformation of customer engagement
• Led business analytics and sales force effectiveness initiatives
• Contributed to pre-launch and launch preparation of innovative HIV therapies

Key achievements:

• Consistently ranked among top performers across multiple therapeutic areas
• Contributed to multiple successful product launches across hospital and specialty care markets
• Developed strong hospital networks and KOL engagement across cardiology, neurology, infectious diseases and internal medicine
• Led medical education initiatives and physician training programs supporting product adoption
• Contributed to market share growth across hospital and specialist segments